VRI Biomedical is facing legal action in the District Court of Western Australia from a former consultant seeking $135,000.
The writ, from Kalsun director Paul Collier, was lodged with the court on May 19.
Mr Collier declined to comment on the legal action.
VRI company secretary Paul Magoffin confirmed the company had received the writ.
“It relates to a consultancy arrangement we had,” he said. “He [Mr Collier] issued a statement of demand last year. We reject that. We deny any liability.”
The news of the writ comes almost one week after VRI announced it was launching its new range of proTract probiotics to pharmacies around Australia with a roll-out to general practitioners to follow soon.
This is the first large-scale distribution of its over-the-counter probiotics to the market.
The company also survived a turbulent year in 2003, when shareholder Australian Heritage Group launched a campaign to unseat VRI founder and chairman Leon Ivory.
Mr Ivory was ousted in May by the merchant bank’s campaign, led by AHG director Sally Capp. Fellow VRI director Ken Baxter – a director of Pan Pharmaceuticals – also stepped down.
While Ms Capp has quit Western Australia for Victoria, she remains a non-executive director on VRI’s board.
